Intuitive Surgical, Inc. $ISRG Shares Sold by Valley Brook Capital Group Inc.

Valley Brook Capital Group Inc. lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 485 shares of the medical equipment provider’s stock after selling 25 shares during the quarter. Valley Brook Capital Group Inc.’s holdings in Intuitive Surgical were worth $264,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the business. Aaron Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares in the last quarter. Crown Wealth Group LLC lifted its position in shares of Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after purchasing an additional 20 shares in the last quarter. FSM Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after purchasing an additional 20 shares in the last quarter. CFO4Life Group LLC lifted its position in shares of Intuitive Surgical by 4.8% during the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 20 shares in the last quarter. Finally, J. W. Coons Advisors LLC increased its stake in shares of Intuitive Surgical by 1.4% during the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after buying an additional 20 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 3.2%

Shares of Intuitive Surgical stock opened at $429.59 on Friday. The firm has a market capitalization of $154.00 billion, a P/E ratio of 59.91, a P/E/G ratio of 4.51 and a beta of 1.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm’s 50 day moving average is $458.68 and its two-hundred day moving average is $497.91.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue was up 21.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.78 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently weighed in on ISRG. UBS Group upped their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. The Goldman Sachs Group cut their target price on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday, October 1st. Royal Bank Of Canada restated an “outperform” rating and set a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, Truist Financial upped their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $589.43.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 over the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.